{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:48:00Z","timestamp":1791406080543,"version":"4.3.3"},"reference-count":47,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1TR001450"],"award-info":[{"award-number":["UL1TR001450"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["U54-GM104941"],"award-info":[{"award-number":["U54-GM104941"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1053\/j.ajkd.2017.12.002","type":"journal-article","created":{"date-parts":[[2018,2,23]],"date-time":"2018-02-23T02:48:30Z","timestamp":1519354110000},"page":"772-782","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["Rapidity of Correction of Hyponatremia Due to Syndrome of Inappropriate Secretion of Antidiuretic Hormone Following Tolvaptan"],"prefix":"10.1053","volume":"71","author":[{"given":"Jesse H.","family":"Morris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole M.","family":"Bohm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Branden D.","family":"Nemecek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Kelley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavna","family":"Bhasin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Nietert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos Q.","family":"Velez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1053\/j.ajkd.2017.12.002_bib1","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s11011-010-9175-0","article-title":"Central pontine myelinolysis: historical and mechanistic considerations","volume":"25","author":"Norenberg","year":"2010","journal-title":"Metab Brain Dis"},{"issue":"24","key":"10.1053\/j.ajkd.2017.12.002_bib2","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1056\/NEJM198606123142402","article-title":"Osmotic demyelination syndrome following correction of hyponatremia","volume":"314","author":"Sterns","year":"1986","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1053\/j.ajkd.2017.12.002_bib3","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/ana.410270110","article-title":"Central pontine myelinolysis and pontine lesions after rapid correction of hyponatremia: a prospective magnetic resonance imaging study","volume":"27","author":"Brunner","year":"1990","journal-title":"Ann Neurol"},{"issue":"4486","key":"10.1053\/j.ajkd.2017.12.002_bib4","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1126\/science.7466381","article-title":"Rapid correction of hyponatremia causes demyelination: relation to central pontine myelinolysis","volume":"211","author":"Kleinschmidt-Demasters","year":"1981","journal-title":"Science"},{"issue":"6","key":"10.1053\/j.ajkd.2017.12.002_bib5","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/ana.410150606","article-title":"Chronicity of hyponatremia as a factor in experimental myelinolysis","volume":"15","author":"Norenberg","year":"1984","journal-title":"Ann Neurol"},{"issue":"6","key":"10.1053\/j.ajkd.2017.12.002_bib6","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1038\/ki.1991.161","article-title":"Neurological and neuropathological sequelae of correction of chronic hyponatremia","volume":"39","author":"Verbalis","year":"1991","journal-title":"Kidney Int"},{"issue":"34","key":"10.1053\/j.ajkd.2017.12.002_bib7","article-title":"A\u00a0case of osmotic demyelination syndrome occurred after the correction of severe hyponatraemia in hyperemesis gravidarum","volume":"14","author":"Corona","year":"2014","journal-title":"BMC Endocr Disord"},{"issue":"1","key":"10.1053\/j.ajkd.2017.12.002_bib8","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1742-1241.1995.tb09883.x","article-title":"Extrapontine myelinolysis after correction of chronic hyponatraemia with isotonic saline","volume":"49","author":"Ellis","year":"1995","journal-title":"Br J Clin Pract"},{"issue":"4","key":"10.1053\/j.ajkd.2017.12.002_bib9","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/ki.2012.402","article-title":"Where vaptans do and do not fit in the treatment of hyponatremia","volume":"83","author":"Jovanovich","year":"2013","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2017.12.002_bib10","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/807054","article-title":"Unpredictable nature of tolvaptan in treatment of hypervolemic hyponatremia: case review on role of vaptans","author":"Malhotra","year":"2014","journal-title":"Case Rep Endocrinol"},{"key":"10.1053\/j.ajkd.2017.12.002_bib11","unstructured":"US Food & Drug Administration, US Department of Health and Human Services. Samsca (tolvaptan) tablets. September 28, 2011. www.accessdata.fda.gov\/drugsatfda_docs\/appletter\/2011\/022275s003ltr.pdf. Accessed March 14,\u00a02017."},{"issue":"20","key":"10.1053\/j.ajkd.2017.12.002_bib12","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1056\/NEJMoa065181","article-title":"Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia","volume":"355","author":"Schrier","year":"2006","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1053\/j.ajkd.2017.12.002_bib13","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4158\/EP10386.CR","article-title":"Tolvaptan for the management of syndrome of inappropriate antidiuretic hormone secretion: lessons learned in titration of dose","volume":"17","author":"Torres","year":"2011","journal-title":"Endocr Pract"},{"issue":"3","key":"10.1053\/j.ajkd.2017.12.002_bib14","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s11255-011-9996-8","article-title":"Serum and urine responses to the aquaretic agent tolvaptan in hospitalized hyponatremic patients","volume":"44","author":"Vaghasiya","year":"2012","journal-title":"Int Urol Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2017.12.002_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13613-015-0096-2","article-title":"Tolvaptan for hyponatremia with preserved sodium pool in critically ill patients","volume":"6","author":"Umbrello","year":"2016","journal-title":"Ann Intensive Care"},{"issue":"5","key":"10.1053\/j.ajkd.2017.12.002_bib16","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1093\/ndt\/gfp731","article-title":"Intravenous conivaptan for the treatment of hyponatraemia caused by the syndrome of inappropriate secretion of antidiuretic hormone in hospitalized patients: a single-centre experience","volume":"25","author":"Velez","year":"2010","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1053\/j.ajkd.2017.12.002_bib17","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.2215\/CJN.04431007","article-title":"Clinical laboratory evaluation of the syndrome of inappropriate secretion of antidiuretic hormone","volume":"3","author":"Decaux","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2017.12.002_bib18","series-title":"Clinical Physiology of Acid-Base and Electrolyte Disorders","first-page":"703","author":"Rose","year":"2001"},{"key":"10.1053\/j.ajkd.2017.12.002_bib19","series-title":"Handbook of Nephrology & Hypertension","first-page":"109","article-title":"Disorders of water balance","author":"Segal","year":"2009"},{"issue":"5","key":"10.1053\/j.ajkd.2017.12.002_bib20","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1530\/EJE-10-1078","article-title":"Efficacy and safety of oral tolvaptan therapy in patients with the syndrome of inappropriate antidiuretic hormone secretion","volume":"164","author":"Verbalis","year":"2011","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"10.1053\/j.ajkd.2017.12.002_bib21","doi-asserted-by":"crossref","first-page":"247","DOI":"10.7326\/0003-4819-145-4-200608150-00004","article-title":"Using standardized serum creatinine values in the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate","volume":"145","author":"Levey","year":"2006","journal-title":"Ann Intern Med"},{"issue":"9","key":"10.1053\/j.ajkd.2017.12.002_bib22","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A\u00a0new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.ajkd.2017.12.002_bib23","series-title":"Applied Longitudinal Analysis","author":"Fitzmaurice","year":"2004"},{"issue":"2","key":"10.1053\/j.ajkd.2017.12.002_bib24","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.2041-210x.2012.00261.x","article-title":"A\u00a0general and simple method for obtaining R2 from generalized linear mixed-effects models","volume":"4","author":"Nakagawa","year":"2013","journal-title":"Methods Ecol Evol"},{"issue":"12","key":"10.1053\/j.ajkd.2017.12.002_bib25","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1001\/jama.297.12.1332","article-title":"Short term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials","volume":"297","author":"Gheorghiade","year":"2007","journal-title":"JAMA"},{"issue":"10","key":"10.1053\/j.ajkd.2017.12.002_bib26","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1007\/s00228-016-2091-4","article-title":"Risk factors for hypernatremia in patients with short- and long-term tolvaptan treatment","volume":"72","author":"Hirai","year":"2016","journal-title":"Eur J Clin Pharmacol"},{"issue":"12","key":"10.1053\/j.ajkd.2017.12.002_bib27","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1093\/annonc\/mdr431","article-title":"High sensitivity to tolvaptan in paraneoplastic syndrome of inappropriate ADH secretion (SIADH)","volume":"22","author":"Kenz","year":"2011","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1053\/j.ajkd.2017.12.002_bib28","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/cen.12943","article-title":"Real-life experience of tolvaptan use in the treatment of severe hyponatremia due to syndrome of inappropriate antidiuretic hormone secretion","volume":"84","author":"Tzoulis","year":"2016","journal-title":"Clin Endocrinol"},{"issue":"3","key":"10.1053\/j.ajkd.2017.12.002_bib29","first-page":"138","article-title":"[Lower doses of tolvaptan in hyponatremia due to the syndrome of inappropriate antidiuretic hormone secretion.]","volume":"145","author":"Sanchez-Sobrino","year":"2015","journal-title":"Med Clin (Barc)"},{"issue":"5","key":"10.1053\/j.ajkd.2017.12.002_bib30","doi-asserted-by":"crossref","first-page":"716","DOI":"10.7326\/0003-4819-93-5-716","article-title":"Hypouremia in the syndrome of inappropriate secretion of antidiuretic hormone","volume":"93","author":"Decaux","year":"1980","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1053\/j.ajkd.2017.12.002_bib31","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1023\/A:1017586004688","article-title":"Utility and limitations of biochemical parameters in the evaluation of hyponatremia in the elderly","volume":"32","author":"Musch","year":"2001","journal-title":"Int Urol Nephrol"},{"issue":"5","key":"10.1053\/j.ajkd.2017.12.002_bib32","doi-asserted-by":"crossref","first-page":"909","DOI":"10.2215\/CJN.00320106","article-title":"Age related increase in plasma urea level and decrease in fractional urea excretion: clinical application in SIADH","volume":"1","author":"Musch","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.ajkd.2017.12.002_bib33","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/ki.2011.119","article-title":"Short-term effects of tolvaptan on renal function and volume in patients with autosomal dominant polycystic kidney disease","volume":"80","author":"Irazabal","year":"2011","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.ajkd.2017.12.002_bib34","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/ki.2015.4","article-title":"Current treatment practice and outcomes. Report of the hyponatremia registry","volume":"88","author":"Greenberg","year":"2015","journal-title":"Kidney Int"},{"issue":"3","key":"10.1053\/j.ajkd.2017.12.002_bib35","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s11255-008-9353-8","article-title":"Observations regarding the use of the aquaretic agent conivaptan for treatment of hyponatremia","volume":"40","author":"Metzger","year":"2008","journal-title":"Int Urol Nephrol"},{"issue":"5","key":"10.1053\/j.ajkd.2017.12.002_bib36","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1159\/000106456","article-title":"Assessment of the efficacy and safety of intravenous conivaptan in euvolemic and hypervolemic hyponatremia","volume":"27","author":"Zeltser","year":"2007","journal-title":"Am J Nephrol"},{"issue":"6.2","key":"10.1053\/j.ajkd.2017.12.002_bib37","first-page":"1617","article-title":"Pathogenesis of hyponatremia in an experimental model of the syndrome of inappropriate antidiuresis","volume":"267","author":"Verbalis","year":"1994","journal-title":"Am J Physiol"},{"issue":"6.2","key":"10.1053\/j.ajkd.2017.12.002_bib38","first-page":"1036","article-title":"A\u00a0mechanism by which atrial natriuretic factor mediates its glomerular actions","volume":"251","author":"Appel","year":"1986","journal-title":"Am J Physiol"},{"issue":"4.2","key":"10.1053\/j.ajkd.2017.12.002_bib39","first-page":"710","article-title":"Atrial natriuretic factor can increase renal solute excretion primarily by raising glomerular filtration","volume":"250","author":"Cogan","year":"1986","journal-title":"Am J Physiol"},{"issue":"3.1","key":"10.1053\/j.ajkd.2017.12.002_bib40","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/0002-9343(88)90260-4","article-title":"Natriuresis and atrial natriuretic factor secretion during inappropriate antidiuresis","volume":"84","author":"Cogan","year":"1988","journal-title":"Am J Med"},{"issue":"6","key":"10.1053\/j.ajkd.2017.12.002_bib41","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1080\/00365517809108822","article-title":"Factors limiting renal proximal tubular reabsorption at high glomerular filtration rate","volume":"38","author":"Mathisen","year":"1978","journal-title":"Scand J Clin Lab Invest"},{"issue":"10","key":"10.1053\/j.ajkd.2017.12.002_bib42","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1056\/NEJM197909063011005","article-title":"Hypouricemia in the syndrome of inappropriate secretion of antidiuretic hormone","volume":"301","author":"Beck","year":"1979","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1053\/j.ajkd.2017.12.002_bib43","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1159\/000187312","article-title":"Evidence of defective tubular reabsorption and normal secretion of uric acid in the syndrome of inappropriate secretion of antidiuretic hormone","volume":"64","author":"Prospert","year":"1993","journal-title":"Nephron"},{"issue":"5","key":"10.1053\/j.ajkd.2017.12.002_bib44","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1042\/cs0780451","article-title":"Dissociation between uric acid and urea clearances in the syndrome of inappropriate secretion of antidiuretic hormone related to salt excretion","volume":"78","author":"Decaux","year":"1990","journal-title":"Clin Sci (Lond)"},{"issue":"5","key":"10.1053\/j.ajkd.2017.12.002_bib45","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/00041552-200409000-00008","article-title":"Renal urea transporters","volume":"13","author":"Sands","year":"2004","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"4","key":"10.1053\/j.ajkd.2017.12.002_bib46","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1152\/ajprenal.00497.2013","article-title":"Global analysis of the effects of the V2 receptor antagonist satavaptan on protein phosphorylation in collecting duct","volume":"306","author":"Hoffert","year":"2014","journal-title":"Am J Physiol Renal Physiol"},{"issue":"8","key":"10.1053\/j.ajkd.2017.12.002_bib47","first-page":"105","article-title":"Role of tolvaptan in the management of hyponatremia in patients with lung and other cancers: current data and future perspectives","volume":"22","author":"Thajudeen","year":"2016","journal-title":"Cancer Manag Res"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638618300040?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638618300040?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T03:05:11Z","timestamp":1759460711000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638618300040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0272638618300040"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2017.12.002","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rapidity of Correction of Hyponatremia Due to Syndrome of Inappropriate Secretion of Antidiuretic Hormone Following Tolvaptan","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2017.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}]}}